Cardiogenesis Corporation
Medical Equipment ManufacturingGeorgia, United States11-50 Employees
Cardiogenesis Corporation, a wholly owned subsidiary of CryoLife since its 2011 acquisition, develops medical devices for cardiovascular treatment. Based in Kennesaw, Georgia, it operates in the medical equipment manufacturing sector and markets a laser-based system with disposable delivery components used to perform Transmyocardial Revascularization. The system is approved by the FDA for distribution in the United States and is CE-marked for Europe. Transmyocardial Revascularization targets patients with chronic stable angina who do not respond to medical management and for whom stenting or bypass surgery is no longer an option, with long-term results described as demonstrating efficacy. The company is expanding the platform by integrating laser therapy with autologous cell delivery in a single system, and in December 2025 appointed Raymond W. Cohen to its Board of Directors.